Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.2458
+0.0119 (5.09%)
Jul 3, 2025, 1:00 PM - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $8.26 million as of July 3, 2025. Its market cap has decreased by -34.03% in one year.
Market Cap
8.26M
Enterprise Value
2.40M
1-Year Change
-34.03%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $8.26M, a decrease of -96.98%. That is a compound annual growth rate of -61.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 8.26M | -62.83% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.61B |
| Johnson & Johnson | 375.83B |
| AbbVie | 335.46B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 281.10B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.26B |
| AstraZeneca | 219.33B |